Vasodilator effects of enalapril in patients with arterial hypertension
- PMID: 3022512
Vasodilator effects of enalapril in patients with arterial hypertension
Abstract
Although it has been recognized that enalapril lowers blood pressure by reducing the total peripheral vascular resistance, its direct effect on blood vessels is largely unknown. Little information is available about the influence of enalapril on the different vascular regions. Ten patients with moderate essential hypertension were treated with enalapril 20 mg daily in a double-blind, placebo controlled cross-over study for six weeks during each period. Blood pressure and heart rate were measured in supine, sitting and standing position. Venous capacity was derived from pressure volume curves plotted simultaneously at forearm and calf. Arterial blood flow at rest and during reactive hyperemia was measured at calf and finger by plethysmography. Enalapril increases venous capacity in upper and lower limbs in patients with moderate essential hypertension. Also, there is vasodilation of calf and finger arteries both at rest and during reactive hyperemia. Finger and calf arteries contribute to the decrease of the total peripheral vascular resistance during treatment with enalapril; thus, ACE inhibition is capable of correcting the increased peripheral resistance which often is the main cause of arterial hypertension.
Similar articles
-
Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.J Clin Hypertens. 1987 Dec;3(4):520-7. J Clin Hypertens. 1987. PMID: 2839628 Clinical Trial.
-
Effect of oral MK-421 and propranolol on the forearm arterial circulation in essential hypertension: a preliminary report.J Hypertens Suppl. 1983 Oct;1(1):101-2. J Hypertens Suppl. 1983. PMID: 6100597 Clinical Trial.
-
The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.J Hypertens. 1994 Sep;12(9):1047-52. J Hypertens. 1994. PMID: 7852748 Clinical Trial.
-
ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.Angiology. 1996 Mar;47(3):233-40. doi: 10.1177/000331979604700303. Angiology. 1996. PMID: 8638865 Clinical Trial.
-
Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm.Am J Cardiol. 1984 Mar 1;53(6):781-5. doi: 10.1016/0002-9149(84)90403-x. Am J Cardiol. 1984. PMID: 6322565 Clinical Trial.
Cited by
-
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD003823. doi: 10.1002/14651858.CD003823.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous